Skip to main content
. 2022 Mar 15;37(11):e90. doi: 10.3346/jkms.2022.37.e90

Table 1. Auxological and biochemical characteristics in participants.

Parameters Idiopathic GHD Organic GHD P valueb
Total (N = 131) Male (n = 83) Female (n = 48) P valuea Total (N = 32) Male (n = 17) Female (n = 15) P valuea
CA, yr 7.50 ± 2.91 7.57 ± 3.18 7.38 ± 2.40 0.926 9.72 ± 3.58 9.53 ± 3.51 9.93 ± 3.76 0.761 0.001
BA, yr 5.45 ± 2.92 5.51 ± 3.25 5.33 ± 2.30 0.698 7.24 ± 3.73 7.09 ± 3.29 7.47 ± 4.53 0.821 0.018
CA-BA, yr 1.89 ± 0.99 1.92 ± 1.04 1.83 ± 0.92 0.631 2.04 ± 1.28 2.18 ± 1.25 1.82 ± 1.37 0.520 0.530
Ht SDS −2.84 ± 0.75 −2.77 ± 0.72 −2.96 ± 0.80 0.232 −2.21 ± 1.50 −2.54 ± 1.33 −1.83 ± 1.64 0.201 0.043
Wt SDS −1.95 ± 1.12 −2.04 ± 0.94 −1.80 ± 1.37 0.340 −1.17 ± 1.49 −1.57 ± 1.01 −0.70 ± 1.82 0.129 0.011
BMI SDS −0.31 ± 1.22 −0.49 ± 1.11 0.01 ± 1.35 0.055 0.06 ± 1.23 −0.20 ± 0.85 0.35 ± 1.53 0.243 0.099
MPH SDS −0.75 ± 0.77 −0.61 ± 0.70 −0.98 ± 0.84 0.013 0.09 ± 0.59 −0.06 ± 0.51 0.22 ± 0.64 0.243 < 0.001
PAH SDS −1.81 ± 1.10 −1.66 ± 1.07 −2.10 ± 1.13 0.205 −0.33 ± 2.02 −0.20 ± 2.21 −0.59 ± 1.87 0.770 0.031
Prepubertalc 44 (86.2) 17 (85.0) 27 (87.1) 0.832 14 (82.4) 7 (70.0) 7 (100) 0.110 0.693
Ht SDS–MPH SDS −2.04 ± 0.90 −2.06 ± 0.83 −2.01 ± 1.04 0.821 −2.32 ± 0.94 −2.28 ± 1.08 −2.35 ± 0.84 0.862 0.179
IGF-1 SDS −0.71 ± 0.92 −0.67 ± 0.90 −0.78 ± 0.98 0.992 −0.45 ± 2.78 −0.03 ± 3.50 −0.92 ± 1.79 1.000 0.045
IGFBP-3 SDS −0.44 ± 1.75 −0.31 ± 1.54 −0.70 ± 2.12 0.373 −0.45 ± 3.03 −0.51 ± 3.72 −0.38 ± 1.92 0.306 0.270
Peak GH level on GHST, μg/L 6.47 ± 2.54 6.58 ± 2.46 6.28 ± 2.69 0.683 2.22 ± 2.42 2.26 ± 2.74 2.18 ± 2.09 0.925 < 0.001
Initial GH dose, mg/kg/week 0.23 ± 0.05 0.23 ± 0.05 0.23 ± 0.04 0.494 0.20 ± 0.07 0.23 ± 0.06 0.17 ± 0.07 0.017 0.026
Mean GH dose during 3 yr of GH treatment, mg/kg/week 0.23 ± 0.04 0.23 ± 0.04 0.23 ± 0.04 0.736 0.19 ± 0.06 0.22 ± 0.04 0.17 ± 0.07 0.034 0.001

Values are presented as number (%) or mean ± standard deviation.

GHD = growth hormone deficiency, CA = chronological age, BA = bone age, Ht = height, SDS = standard deviation score, Wt = weight, BMI = body mass index, MPH = mid-parental height, PAH = predicted adult height, IGF-1 = insulin like growth factor-1, IGFBP-3 = insulin like growth factor-binding protein-3, GH = growth hormone, GHST = growth hormone stimulation test.

P values are calculated with independent t-test or Wilcoxon rank sum test: amale vs. female; bIGHD vs. OGHD.

cThis variable was analyzed from only available participants: IGHD (n = 51) and OGHD (n = 17).